Ginormous legal affairs dept full of morons.
Fuck Israel
They're also on the limit of their production capability, its not as if they're overproducing to cover yield and can still deliver.KEN-JENNINGS wrote:
Poor yield is purely on the manufacturer, and never an excuse for "best effort". Yield rate is a cost-based variable, and as such needs to be understood by the manufacturer prior to negotiating pricing and lead times. You can't agree to produce a quantity of something by a specific time frame at a specific price without knowing that information. There's no doubt these pharma companies had to make certain gambles as far as materials procurement and production quantities in order to meet demand immediately after government approval, but without gigantic margins, there's no way a manufacturer can deal with yield rate fluctuations and still turn a profit.
The best effort tends to address things like redirecting production to other business, not securing capacity or components dependent on lead times and availability, failing to get proper regulatory compliance and approvals, etc.
I would almost guarantee there are specifics around where the manufacturing is being done and how that relates to lead times. That's probably why the EU is complaining.
As an aside, the only time I ever saw a force majuere clause used was when we had a container of product stolen in transit. Even the Japanese Tsunami that wiped out chip production didn't trigger that clause, because no one in their right mind is going to bitch and moan about something like that.
Last edited by Dilbert_X (2021-01-28 17:19:01)